🖼️00Read later0Read MoreCohance Lifesciences: Can a recovery justify its valuation?The Indian Express·Rahul Rao·13 days ago#2eZ6v03z#indianexpress#cohance#lifesciences#revenue#fell+3 more🧰Tag tools✨Add tagCohance Lifesciences business numbers have been hard to stomach. FY26 revenue fell 13% and adjusted EBITDA nearly halved. Q1 FY27 revenue fell 23%, adjusted EBITDA margin dropped to 2.2%, and the company reported a net loss of Rs 45 crore.… Read more15s